Related Experiment Video
Updated: Mar 29, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Measles 50 Years After Use of Measles Vaccine
James L Goodson1, Jane F Seward2
1Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, 1600 Clifton Road, Northeast, MS A-04, Atlanta, GA 30333, USA.
Abstract:
In response to severe measles, the first measles vaccine was licensed in the United States in 1963. Widespread use of measles vaccines for more than 50 years has significantly reduced global measles morbidity and mortality. However, measles virus continues to circulate, causing infection, illness, and an estimated 400 deaths worldwide each day. Measles is preventable by vaccine, and humans are the only reservoir. Clinicians should promote and provide on-time vaccination for all patients and keep measles in their differential diagnosis of febrile rash illness for rapid case detection, confirmation of measles infection, isolation, treatment, and appropriate public health response.
Related Concept Videos
Vaccinations
Vaccines
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Microorganisms in Medicine and Therapeutics
Cross-reactivity
Vaccine Production

